Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, vol.63, no.2, pp.94-101, 2015 (ESCI, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 63 Issue: 2
- Publication Date: 2015
- Doi Number: 10.5578/tt.9110
- Journal Name: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.94-101
- Keywords: Community acquired pneumonia, ampicilline-sulbactam, fluoroquinolone
- Akdeniz University Affiliated: Yes
Abstract
Introduction: For hospitalized patients, monotherapy with a respiratory Fluoroquinolone (F) and dual therapy combination a ampicilline-sulbactam + a macrolide (AS+ M) are extensively used in the treatment of community-acquiredpneumonia (CAP). In this study, empirical AS + M combination therapy versus F monotherapy was compared in hospitalized adult CAP patients.